- Home
- PAHC vs TLRY Comparison
PAHC vs TLRY Comparison
Compare PAHC & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAHC
- TLRY
- Stock Information
- Founded
- PAHC 1946
- TLRY N/A
- Country
- PAHC United States
- TLRY Canada
- Employees
- PAHC N/A
- TLRY N/A
- Industry
- PAHC Biotechnology: Pharmaceutical Preparations
- TLRY Medicinal Chemicals and Botanical Products
- Sector
- PAHC Health Care
- TLRY Health Care
- Exchange
- PAHC Nasdaq
- TLRY Nasdaq
- Market Cap
- PAHC 1.5B
- TLRY 1.7B
- IPO Year
- PAHC 2014
- TLRY 2018
- Fundamental
- Price
- PAHC $44.48
- TLRY $1.03
- Analyst Decision
- PAHC Hold
- TLRY Buy
- Analyst Count
- PAHC 4
- TLRY 3
- Target Price
- PAHC $31.25
- TLRY $1.50
- AVG Volume (30 Days)
- PAHC 324.6K
- TLRY 50.3M
- Earning Date
- PAHC 11-05-2025
- TLRY 10-09-2025
- Dividend Yield
- PAHC 1.06%
- TLRY N/A
- EPS Growth
- PAHC 288.74
- TLRY N/A
- EPS
- PAHC 1.67
- TLRY N/A
- Revenue
- PAHC $1,399,676,000.00
- TLRY $830,766,000.00
- Revenue This Year
- PAHC $14.80
- TLRY $7.32
- Revenue Next Year
- PAHC $3.16
- TLRY $4.49
- P/E Ratio
- PAHC $27.13
- TLRY N/A
- Revenue Growth
- PAHC 33.72
- TLRY 2.31
- 52 Week Low
- PAHC $16.16
- TLRY $0.35
- 52 Week High
- PAHC $46.42
- TLRY $2.32
- Technical
- Relative Strength Index (RSI)
- PAHC 62.55
- TLRY 33.03
- Support Level
- PAHC $43.71
- TLRY $1.17
- Resistance Level
- PAHC $44.00
- TLRY $1.33
- Average True Range (ATR)
- PAHC 2.15
- TLRY 0.07
- MACD
- PAHC 0.08
- TLRY -0.03
- Stochastic Oscillator
- PAHC 73.40
- TLRY 3.66
About PAHC Phibro Animal Health Corporation
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mostly from alcohol.